CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 163750-164041 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/038354e8830fe01feb621a12e8a8c467a15b6354","sourcedb":"CORD-19","sourceid":"038354e8830fe01feb621a12e8a8c467a15b6354","text":"NA mutations detected in clinical isolates, which confer resistance to the available neuraminidase inhibitors (NAI), include E119Vand H274Y, which confer resistance to oseltamivir only, and R292K and R152K, which confer resistance to both oseltamivir and zanamivir (Wetherall et al., 2003) .","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1023","span":{"begin":0,"end":291},"obj":"Sentence"},{"id":"T43398","span":{"begin":0,"end":291},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1023","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T43398","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T91","span":{"begin":0,"end":291},"obj":"Sentence"}],"attributes":[{"subj":"T91","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#9c93ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#a4ec93"}]}]}}